Regulatory Compliance

JumpCloud Expands IAM Platform to Govern Autonomous AI Agents

Louisville, Colo. – September 16, 2026 -- JumpCloud Inc. has extended its identity and access management platform to govern AI agents alongside human employees and devices, addressing a gap where only 21% of IT teams have adopted governance controls for autonomous agents.

JumpCloud ties every AI agent to a verified human owner and lifecycle record

The platform now treats each AI agent as a distinct identity, tracked from creation to retirement. Agents registered in JumpCloud cannot operate without an assigned human owner, giving IT teams a centralized view of every agent in use across the organization.

NuxGame to Showcase Open iGaming Ecosystem at SBC Summit Lisbon 2026

Limassol – – September 16, 2026 -- NuxGame, a B2B iGaming software provider founded in 2018, will host operators, affiliates and partners at Stand A326 in Hall 1 of SBC Summit Lisbon 2026, running Sept. 29 to Oct. 1 at the Feira Internacional de Lisboa.

NuxGame sponsors the summit's Networking Lounge in Hall 1

The company's stand doubles as the event's Networking Lounge, giving operators direct access to NuxGame's product and commercial teams for one-on-one sessions across all three days.

SQAIRZ Launches Medical Division to Tackle $80B Fall-Risk Crisis

Windham, N.H. – September 16, 2026 -- SQAIRZ, a biomechanically driven performance footwear company, has launched SQAIRZ Medical, a new division targeting fall risk among aging adults through a combined footwear and clinical assessment platform.

Fall injuries cost the U.S. healthcare system more than $80 billion annually

One in four U.S. adults over age 65 falls at least once a year, a figure that rises to one in two for adults over 80, according to SQAIRZ. The company positions SENTRX, its purpose-built Balance & Stability footwear, as the centerpiece of a broader clinical framework aimed at reducing that risk.

Biological Safety Cabinet Market to Hit $0.36B by 2031, Kewaunee Leads M&A

Delray Beach, Fla. – September 16, 2026 -- The global biological safety cabinet market is projected to grow from USD 0.26 billion in 2026 to USD 0.36 billion by 2031, a 6.6% CAGR, according to MarketsandMarkets.

Pharma investment and biosafety upgrades drive containment equipment demand

Expansion of drug discovery, biologics, cell and gene therapy, and vaccine development is pushing laboratories to replace aging cabinets with certified, higher-performance containment systems. Rising biosafety requirements for handling infectious agents and hazardous materials are accelerating both new installations and equipment upgrades across clinical, academic, and pharmaceutical labs.

ProphetX Brings CFTC-Regulated Sports Markets Onchain via Agg, Solana

New York – September 16, 2026 -- ProphetX, America's first federally regulated sports-native prediction market, has partnered with Agg Market to move its full contract catalog onto the Solana blockchain, delivering 100% market coverage through the integration from launch.

ProphetX opens CFTC-regulated contracts to onchain traders via Agg's Solana infrastructure

Every contract listed on ProphetX is now accessible through Agg Market's Solana-based integration, giving onchain traders and builders a direct channel into a federally supervised sports prediction venue. The arrangement does not alter the terms, execution, or settlement framework of ProphetX-listed contracts.

Claroty Public Sector Achieves CJIS Compliance With Fortreum

Arlington, Va. – September 16, 2026 -- Claroty Public Sector LLC's xDome for Government platform has achieved compliance with the FBI's Criminal Justice Information Services (CJIS) Security Policy, the company announced in partnership with cybersecurity advisory firm Fortreum.

Compliance targets protection of criminal justice data confidentiality and integrity

The CJIS certification confirms Claroty's cyber-physical systems (CPS) platform meets the FBI's security requirements for handling sensitive criminal justice information. Law enforcement and public safety agencies face mounting pressure to secure a growing base of connected and legacy infrastructure, including weapons platforms, building management systems, operational technology, and IoT devices, while limiting third-party and vendor risk.

Federal Contract Cycles Nearly Double Global Benchmark, Report Finds

Reston, Va. – September 16, 2026 -- Federal acquisition organizations report contract cycle times nearly twice the global benchmark for lower-complexity acquisitions, according to the 2026 US Government Benchmark Report released by the Commerce & Contract Management Institute (CCM Institute).

Federal workers report higher resilience despite structural delays

The study, based on responses from more than 500 federal acquisition professionals and industry suppliers, found federal respondents scoring 5.0 on workforce resilience and 4.6 on adaptability, outperforming global benchmarks of 4.8 and 4.2 respectively. Yet 66 percent of respondents cited ongoing uncertainty and 64 percent cited operational workload as major barriers to organizational agility.

Saudi Arabia Nominates Dr Hanan Balkhy for WHO Director-General

Riyadh – September 16, 2026 -- Dr Hanan H. Balkhy, WHO Regional Director for the Eastern Mediterranean, has launched her candidacy for WHO Director-General after being nominated by the Kingdom of Saudi Arabia, pledging to build "a WHO the world can count on."

Saudi Arabia backs a 30-year public health veteran for WHO's top post

Dr Balkhy, trained in Saudi Arabia and the United States, has spent more than three decades in clinical medicine, academic research and international public health leadership. She currently oversees WHO operations across 22 Member States and more than 750 million people as Regional Director for the Eastern Mediterranean, and previously served as WHO's first Assistant Director-General for Antimicrobial Resistance and as a member of the Organization's Global Policy Group.

CytoSorbents Execs to Present at H.C. Wainwright Investor Conference

Princeton, N.J. – – September 16, 2026 -- CytoSorbents Corporation (NASDAQ: CTSO) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14–16, 2026, as the blood-purification device maker seeks to update investors on its regulatory pipeline and path to profitability.

CEO and CFO to join fireside chat on September 14

Dr. Phillip Chan, Chief Executive Officer, and Peter Mariani, Chief Financial Officer, will join Sean Lee, Vice President of Equity Research at H.C. Wainwright, for a fireside chat at 11:30 a.m. EDT at the Lotte New York Palace Hotel. The two executives will also hold scheduled one-on-one meetings with investors during the three-day event. A webcast replay will remain archived for up to 90 days on the company's investor relations site.

Vincere Biosciences Wins $2.7M NIH Grant for Kidney Injury Drug

Cambridge, Mass. – September 16, 2026 -- Vincere Biosciences has been awarded a $2.7 million Small Business Innovation Research (SBIR) Phase II grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, to fund IND-enabling development of its USP30 inhibitor for acute kidney injury (AKI).

NIH funding targets a disease affecting 13 million people annually

Acute kidney injury impacts more than 13 million people worldwide each year following ischemia, major surgery, or exposure to nephrotoxic drugs, yet treatment remains largely supportive. The two-year grant will fund genotoxicity and toxicology studies, 28-day GLP toxicology studies, and cardiovascular, respiratory, and CNS safety pharmacology required before Vincere can file an Investigational New Drug (IND) application.